Condition
Graft Rejection clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Graft Rejection clinical trials that are recruiting, at sites in 4 countries (most in United States (3), France (1), Austria (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Graft Rejection clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Predicting heart transplant outcomes using donor heart biopsies | — | Vienna, State of Vienna | Recruiting | May 21, 2025 |
| Personalizing adult heart transplant immunosuppression using blood microRNA levels | — | Los Angeles, California and 5 other locations | Recruiting | Apr 23, 2025 |
| Comparing immunosuppression strategies in patients with late renal graft failure | Phase 4 | Barcelona | Recruiting | Nov 6, 2024 |
| Identifying microRNAs to improve heart transplant outcomes in children | — | Aurora, Colorado and 6 other locations | Recruiting | Aug 1, 2024 |
| Understanding how extracorporeal photochemotherapy causes cell death | — | Besançon | Recruiting | Apr 19, 2022 |
| Long-term follow-up care for patients who received stem cell transplants | — | Bethesda, Maryland | Recruiting | Apr 1, 2005 |
All recruiting trials (6)
-
Predicting heart transplant outcomes using donor heart biopsies
This study is testing if looking at tissue samples from donor hearts can help predict how well the transplanted hearts will work and if they'll be rejected by the recipient's body.
-
Personalizing adult heart transplant immunosuppression using blood microRNA levels
This project will try to use blood microRNA patterns to monitor immune status in adults after heart transplant and predict who will develop infection or rejection.
-
Comparing immunosuppression strategies in patients with late renal graft failure
This study is testing whether continuing low-dose immunosuppression or stopping it after six months is better for people with late kidney transplant failure.
-
Identifying microRNAs to improve heart transplant outcomes in children
This study is trying to find specific microRNAs in the blood of children who have had heart transplants to see if they can help predict infections and rejection of the new heart.
-
Understanding how extracorporeal photochemotherapy causes cell death
This study is trying to understand how a treatment called extracorporeal photochemotherapy helps patients with skin lymphomas and graft-versus-host disease by looking at how it causes certain cells to die.
-
Long-term follow-up care for patients who received stem cell transplants
This study looks at how people aged 10 to 80 who received stem cell transplants are doing over time to see how well they respond to treatment and if they have any long-term issues.
Related topics
Quick answers
How many Graft Rejection clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (3 trials), France (1 trial), Austria (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.